Sequenom's Q4 Revenues Drop 11 Percent | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Sequenom reported after the close of the market Monday that its fourth-quarter revenues dropped 11 percent due to lower sales for its MassArray products and services and an increase in spending.

The San Diego-based molecular diagnostics firm generated total revenues of $10.8 million for the three months ended Dec. 31, compared to $12.2 million for the fourth quarter of 2008.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.